Mark Nelson Selected Research

Highly Active Antiretroviral Therapy (HAART)

03/2008	Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.
08/2006	Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma.
05/2006	A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
04/2006	The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe.
11/2005	Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy.
08/2005	A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
12/2004	HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?
02/2004	Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
02/2003	HIV-related lung cancer in the era of highly active antiretroviral therapy.
11/2002	The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma.
03/2002	Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.

6	Acquired Immunodeficiency Syndrome (AIDS) 04/2008 - 02/2004
4	Infection 10/2008 - 11/2005
4	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2006 - 11/2002
3	Giant Lymph Node Hyperplasia (Castleman's Disease) 12/2007 - 09/2004
3	Lymphoma (Lymphomas) 08/2006 - 03/2002
2	Neoplasms (Cancer) 05/2008 - 11/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2008 - 08/2005
2	Hepatitis B 10/2006 - 03/2004
1	Fanconi Syndrome (Syndrome, Fanconi) 07/2008
1	Lactic Acidosis 07/2008
1	Hepatocellular Carcinoma (Hepatoma) 03/2008
1	Hepatitis 03/2008
1	Hodgkin Disease (Hodgkin's Disease) 02/2008
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Hypersensitivity (Allergy) 11/2007
1	Endophthalmitis (Ophthalmia) 10/2006
1	Abscess 10/2006
1	Syndrome 06/2006
1	Macular Edema 10/2005
1	Anus Neoplasms (Anal Cancer) 12/2004
1	Drug Toxicity (Drug Safety) 12/2004
1	Neutropenia 11/2004
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 03/2004
1	Cryptococcal Meningitis 02/2004
1	Lung Neoplasms (Lung Cancer) 02/2003
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2003

2	Lamivudine (3TC)FDA Link 07/2008 - 10/2006
2	Reverse Transcriptase InhibitorsIBA 01/2008 - 07/2003
2	rituximab (Mabthera)FDA Link 12/2007 - 12/2007
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2004 - 07/2003
1	maraviroc FDA Link 10/2008
1	Stavudine (Zerit)FDA Link 07/2008
1	Antidepressive Agents (Antidepressants)IBA 05/2008
1	efavirenz (Sustiva)FDA Link 01/2008
1	HLA-B Antigens (HLA-B)IBA 11/2007
1	abacavir (Ziagen)FDA Link 11/2007
1	Ribavirin (Virazole)FDA LinkGeneric 11/2006
1	Carbon MonoxideIBA 11/2006
1	tenofovirIBA 10/2006
1	beta-Lactamases (beta-Lactamase)IBA 10/2006
1	bivalirudin (Angiomax)FDA Link 06/2006
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2006
1	eszopiclone (Lunesta)FDA Link 11/2005
1	zopiclone (Zop)IBA 11/2005
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 10/2005
1	rofecoxib (Vioxx)FDA Link 12/2004
1	Interleukin-6 (Interleukin 6)IBA 09/2004
1	Monoclonal AntibodiesIBA 09/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	Ritonavir (Norvir)FDA Link 02/2004
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2003

11	Highly Active Antiretroviral Therapy (HAART) 03/2008 - 03/2002
2	Drug Therapy (Chemotherapy) 04/2008 - 11/2004
2	Combination Drug Therapy (Combination Chemotherapy) 03/2004 - 03/2002
1	Transplants (Transplant) 02/2008
1	Activities of Daily Living (ADL) 01/2008
1	Retreatment 12/2007